Associate Professor Tadeusz Osadnik

Associate Professor Tadeusz Osadnik

Medical University of Silesia in Katowice, Zabrze (Poland)

Member of:

Board certified Cardiologist and Clinical Geneticist. Graduate of the Medical University of Silesia (2006). He completed postgraduate studies in molecular biology at the Jagiellonian University (2011). Clinical skills/experience: • Clinical skills cardiology: TTE echocardiography (EACVI certification), TEE echocardiography. Work on regular basis in cardiology outpatient’s clinic. • Clinical skills clinical genetics: counselling and diagnostics of adults and children with suspected genetic diseases. Work on regular basin in genetic outpatient’s clinic Scientific skills: • Methodology of scientific research. •. Statistical analysis; R environment •. Basic bioinformatic skills •. Knowledge of the application, purpose and possibilities provided by tests carried out in a modern genetic laboratory Scientific interests • Integration of clinical information, echocardiography data and data from -omics research. • Personalised medicine

Presentations

Lipoprotein(a) is not a causal factor for the development of diabetes - a two-sample Mendelian randomization study.

Event: ESC Congress 2023

Topic: Lipids

Session: What's new in lipid lowering?

Access

Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study.

Event: ESC Congress 2023

Topic: Pregnancy and Cardiovascular Disease

Session: Predicting and managing maternal cardiovascular risk during pregnancy

Access

Lean metabolic syndrome is associated with similar long-term prognosis as metabolic syndrome in overweight/obese patients. Analysis 47 399 Patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.

Event: ESC Congress 2022

Topic: Obesity

Session: Risk factors - Obesity

Access

Relationship of obesity to mortality in 47 399 patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.

Event: ESC Congress 2022

Topic: Lipids

Session: Obesity and diabetes: key role for risk factor management

Access

Worldwide comparative efficacy of nutraceuticals on lipid profile. an updated systematic review and network meta-analysis

Event: ESC Congress 2022

Topic: Drug therapy

Session: Lipids - Drug therapy 1

Access

Associate Professor Tadeusz Osadnik

Biography

Contributor content

Lipoprotein(a) is not a causal factor for the development of diabetes - a two-sample Mendelian randomization study.

Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study.

Lean metabolic syndrome is associated with similar long-term prognosis as metabolic syndrome in overweight/obese patients. Analysis 47 399 Patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.

Relationship of obesity to mortality in 47 399 patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.

Worldwide comparative efficacy of nutraceuticals on lipid profile. an updated systematic review and network meta-analysis

ESC 365 is supported by